Effect of Celecoxib vs Placebo Added to Standard Adjuvant Therapy on Disease-Free Survival Among Patients With Stage III Colon Cancer

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2021) Hyuna Sung et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Evaluation of the Change of Outcomes over a Ten-Year Period in Patients with Stage III Colon Cancer: Pooled Analysis of 6501 Patients Treated with Fluorouracil, Leucovorin, and Oxaliplatin in the ACCENT Database

(2020) M.E. Salem et al.   ANNALS OF ONCOLOGY

Aspirin as an adjuvant treatment for cancer: feasibility results from the Add-Aspirin randomised trial

(2019) Nalinie Joharatnam-Hogan et al.   Lancet Gastroenterology & Hepatology

Aspirin versus placebo in stage III or high-risk stage II colon cancer with PIK3CA mutation: A French randomised double-blind phase III trial (PRODIGE 50-ASPIK)

(2018) Pierre Michel et al.   DIGESTIVE AND LIVER DISEASE

Duration of Adjuvant Chemotherapy for Stage III Colon Cancer

(2018) Axel Grothey et al.   NEW ENGLAND JOURNAL OF MEDICINE

The ASAMET trial: a randomized, phase II, double-blind, placebo-controlled, multicenter, 2 × 2 factorial biomarker study of tertiary prevention with low-dose aspirin and metformin in stage I-III colorectal cancer patients

(2018) Marilena Petrera et al.   BMC CANCER

Aspirin use after diagnosis but not prediagnosis improves established colorectal cancer survival: a meta-analysis

(2014) Peiwei Li et al.   GUT

Expression of HLA Class I Antigen, Aspirin Use, and Survival After a Diagnosis of Colon Cancer

(2014) Marlies S. Reimers et al.   JAMA Internal Medicine

Aspirin Use and Risk of Colorectal Cancer According to BRAF Mutation Status

(2013) Reiko Nishihara et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Evaluation of PIK3CA Mutation As a Predictor of Benefit From Nonsteroidal Anti-Inflammatory Drug Therapy in Colorectal Cancer

(2013) Enric Domingo et al.   JOURNAL OF CLINICAL ONCOLOGY

Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials

(2012) Annemijn M Algra et al.   LANCET ONCOLOGY

Aspirin Use, TumorPIK3CAMutation, and Colorectal-Cancer Survival

(2012) Xiaoyun Liao et al.   NEW ENGLAND JOURNAL OF MEDICINE

Aspirin in the Chemoprevention of Colorectal Neoplasia: An Overview

(2011) A. T. Chan et al.   Cancer Prevention Research

Capecitabine Plus Oxaliplatin Compared With Fluorouracil and Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer

(2011) Daniel G. Haller et al.   JOURNAL OF CLINICAL ONCOLOGY

The utility of Aspirin in dukes C and high risk dukes B colorectal cancer - The ASCOLT study: study protocol for a randomized controlled trial

(2011) Raghib Ali et al.   Trials

Prediagnostic non-steroidal anti-inflammatory drug use and survival after diagnosis of colorectal cancer

(2010) A. E. Coghill et al.   GUT

Effect of aspirin and NSAIDs on risk and survival from colorectal cancer

(2010) Farhat V N Din et al.   GUT

Phase III Randomized Trial Assessing Rofecoxib in the Adjuvant Setting of Colorectal Cancer: Final Results of the VICTOR Trial

(2010) Rachel S. Midgley et al.   JOURNAL OF CLINICAL ONCOLOGY

Aspirin Use and Survival After Diagnosis of Colorectal Cancer

(2009) Andrew T. Chan   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

A review of gene-drug interactions for nonsteroidal anti-inflammatory drug use in preventing colorectal neoplasia

(2008) J T Cross et al.   PHARMACOGENOMICS JOURNAL